Maureen Stancik Boyce, PhD is a Managing Partner and co-founder at Good Growth Capital. Maureen’s 30+ years of start-up and strategic leadership experience includes serving as co-founder and COO of Ignition Ventures, where she helped start companies out of science labs at MIT, Harvard, Cambridge, and Columbia. Maureen started her strategy career at Bain & Co as a consultant and team leader, in both the Boston and Sydney offices, then became an Associate Partner at IBM’s strategy practice leading Global Strategy Thought Leadership for four industries.
Maureen has been a Mentor for MIT’s Sandbox Innovation accelerator since its launch in January 2016 and has been a part-time Consultant to Sandbox to help with its own growth strategy as it grew from 40 startups a year to 400+ startups each semester. She is an active member of MIT’s Angel community and has been a lecturer at MIT. Maureen won the highest award for MIT alumni for her service to the Institute, the Great Dome Award. She serves as a board member for Eden GeoTech, Aralez Bio, and Blue Ocean Gear in addition to being an observer at Liminal Insights, Radical Plastics and Robigo.
Maureen has served in the US Peace Corps in Fiji, designing and helping to build small water systems as a civil engineer. Maureen has traveled to 60 countries and lived in four, including more than seven years of international work experience in Asia. Maureen received her BS in Civil Engineering, magna cum laude, from Carnegie Mellon, an MBA from MIT Sloan School and a MS and PhD in Engineering from MIT.
Amy brings twenty-four years of experience in finding transformative science companies and leading science-based businesses to the team, having served previously as the CEO of Ignition Ventures, where she and Good Growth Managing Partner Maureen Stancik Boyce helped start companies worth over US $1 billion out of science labs in areas such as chip-based fuel cells, self-organizing networks, selective brain cooling, and advanced materials. Amy is an inventor who holds several patents, speaks internationally about entrepreneurship and leadership, and serves on multiple for-profit and non-profit boards, including ABM Medical, Leuko Labs, Pleural Dynamics, Spiro Robotics, Tevard Biosciences, MTEC, the ASU Interplanetary Initiative, and the Roper St. Francis Hospital Foundation.
Amy’s prior experience also includes writing for magazines like Newsweek, Science, Technology Review, and Harvard Business Review; researching radioactive mutant slime molds; winning a silver medal at the World Championships as a member of the U.S. National Dragonboat Team; and serving as the Assistant Director of a non-profit environmental organization in Washington D.C. She has been featured on the covers of multiple business magazines and her many recognitions include being chosen multiple times as a top “40 Under 40” business leader and being selected by the World Economic Forum as one of its “One Hundred Top Global Leaders for Tomorrow.”
Amy holds an A.B. magna cum laude from Harvard University, an M.Phil in Plant Sciences from Cambridge University where she was a Herschel Smith Harvard Scholar; and an MBA from MIT Sloan School of Management.
Carolyne has over two decades of experience helping companies create and launch products and services, most notably at Apple, where she spent over ten years launching and leading Apple businesses that now account for over half a trillion dollars in revenue. Carolyne held several roles at Apple, including lead producer for the iTunes Music Store US, establishing and leading the store teams, as well as developing the content management system. She led and launched iTunes Europe into 17 countries resulting in number one market share in those locations. launching and leading the App Store into 62 countries simultaneously.
Carolyne is a board member at Unison Computing, Bounce Imaging, and board observer at Pryon. Carolyne is bilingual French/English, has worked and lived in England, Italy, France, and Saint Maarten (Netherlands Antilles), and has traveled extensively. Carolyne received a BA, cum laude, from Connecticut College, and an MBA from Duke University’s Fuqua School of Business, where she was a Fuqua Merit Scholar.
David joined Good Growth from Capital A Partners (“CapA”), where he was a Co-Founder and Managing Partner. CapA was the first VC in South Carolina and has returned over 9x to its investors. He also served as a Managing Director for the Techstars/Arcadis City of 2030 Accelerator (SmartCity focused) in Amsterdam, and was the NYC and London-based Managing Director at Katalyst Venture Partners, a MediaTech-focused fund.
Prior to becoming a venture capitalist, David co-founded then successfully sold VC-backed B2B supply chain software company Supplybase.inc in 2000, with NEA as the lead investor. David spent the first 10 years of his career in several operational roles in engineering, business development and sales with GE, DuPont and Conoco, in the U.S. and U.K. where he managed the sales, technical development and distribution of advanced materials into the Electronics Hardware, Medical Device, Automotive, and Consumer Products sectors. He serves as a board member at Ateios, NALA Membranes, and MFNS and is a board observer at Boston Materials and Lemurian Labs. He has served on the Sr. Advisory Board for the College of Business at Clemson University, as well as on the Advisory Board for Clemson’s Spiro Center of Entrepreneurship and continues to guest lecture at Clemson and other Universities including the Rotterdam School of Business.
David has significant international experience, including working with Conoco in the UK, Katalyst Venture Partners in the UK, Techstars in the Netherlands, and spending his 2nd year of MBA studies at KUL-Leuven (Belgium). David received a BS in Mechanical Engineering from Clemson University, and an MBA from the Kenan-Flagler Business School at UNC Chapel Hill.
John joined Good Growth from his role as Executive Director of The Harbor Entrepreneur Center, a non-profit initiative dedicated to creating collision among entrepreneurs in the region. John co-founded The Harbour, then served as its first executive director for 5 years, during which he mentored 80 start-up companies participating in the Harbor Accelerator program.
John also served as Executive Administrator of Charleston Angel Partners, a group that is an integral part of the start-up ecosystem in the Southeast region. During his tenure, he sourced and facilitated the cumulative investments of over $10M in early stage companies by accredited investors. John is a board member at Bone Health and an observer at Lindy BioSciences. He was also founder & CEO of Fundingcharleston.com.
Prior to that, John spent over 10 years in the financial services industry including in commercial banking, private banking and wealth management for Regions Bank and Bank of America. Using his experience, John helps all Good Growth portfolio companies determine their optimal financial strategy.
John is a scratch golfer, having played competitively in college. John received a BS in Finance, cum laude, from Charleston Southern University, where he played on a golf scholarship.
Sophie is a Principal at Good Growth Capital, where she spends her time focusing on new technology in clean efficient energy storage, natural resources circularity and renewables in Green Tech. She is responsible for managing the inbound deal flow process, due diligence, and assisting with fund administration, including tracking key metrics.
She also has experience in public affairs, market research, and business development. Sophie received an A.B. in Government from Harvard University.
Jennifer is responsible for leading investor relations at Good Growth Capital. She focuses on building and enhancing relationships with new and existing investors. Jennifer joined the firm from HarbourVest Partners, most recently on the ESG team where she worked with clients to understand and help achieve their ESG objectives.
Additionally, she worked with internal stakeholders to implement and monitor ESG standards and practices across the portfolio to advance the principles of sustainable investing. Prior to joining the ESG team, Jennifer was part of the institutional investor relations team at HarbourVest, where she supported the development of relationships with existing and prospective investors and assisted with the Firm’s fundraising efforts. Jennifer previously worked in institutional equity research sales at Wells Fargo Securities. Prior to that, she worked at Wellington Management Company.
Jennifer received a BS in Business Administration in Finance and International Business from the University of Tennessee, and an MBA from Yale School of Management.
Aditi is a Principal at Good Growth Capital, where she focuses her time on exploring the opportunities and cutting edge of data science. Aditi joined the Firm from Invest Detroit Ventures, the most active early stage investor in Michigan. During her time in this role, Aditi was focused on new deal and KPI development, and cultivating relationships with entrepreneurs and ecosystem partners across the Great Lakes region.
Prior to that, Aditi worked at IBM where she worked on proprietary and open source cloud infrastructure products including IBM Cloud, Kubernetes, OpenStack and Docker. During her time in graduate school she interned at various venture funds and at CoderPad where she worked in product and data operations.
Aditi received a BSE in Computer Engineering from the University of Michigan, and a dual degree MBA/MS Data Science from University of Virginia’s Darden School of Business.
Sam is a Senior Associate at Good Growth Capital, and he spends his time focused on identifying and evaluating transformative life sciences companies that aim to address areas of unmet patient need. Sam joined the Firm from previous roles at L.E.K. Consulting & Prescient Healthcare Group. He worked as a life science consultant and provided strategic insights to biotech and pharmaceutical clients, specializing in commercial due diligence, indication expansions, market access, medical affairs, and go-to-market strategies.
Sam received a BA in Biology from Colby College, where he also worked as a research assistant in Professor Ron Peck's microbiology lab.
Mary-Kate is the Operations Manager at Good Growth Capital, where she is responsible for structuring and strengthening the Firm’s internal processes, policies, information design, security, and workflows. Prior to joining the Good Growth team, Mary-Kate worked as an independent consultant advising clients in design and marketing strategy, web development, and fundraising across a range of industries.
She also worked as Director of Operations at Ignite Glass Studios in Chicago. Mary-Kate holds her BA in Linguistics from the University of Oregon, and MA in Design and Management from Ming Chi University of Technology.
Executive Director, Association of Marshall Scholars Former Director of Programming and Education, Edward M. Kennedy Institute for US Senate
Former Faculty RISD Digital+Media Dept. and Mass College of Art & Design Harvard PhD; MIT Media Lab MS; Oxford MS; Yale BA
Bob is a senior executive with over 30 years of leadership experience in healthcare services, healthcare IT, and surgical devices with major international companies, as well as entrepreneurial startups and venture capital. He is well recognized for creating value, with experience in mergers and acquisitions, public corporations, venture capital firms, and startups. Today, Bob is leveraging his healthcare industry and venture capital experience as the Managing Director of Hotspot Ventures, LLC. Hotspot Ventures only works with private capital backed healthcare companies as a strategic advisor, independent board member or executive chairman.
Bob is a venture partner with Good Growth Capital, a venture capital firm in Charleston, SC, the executive chairman of the board for OrbitalRx, a pharmacy shortage supply chain software company in Winston Salem, NC, a strategic advisor and operating partner for Bronze Valley, a CDFI focused on investing in companies founded and/or led by diverse entrepreneurs in Birmingham, AL, is a member of the board of directors for AllerVie, an asthma and allergy practice rollup company in Dallas, TX, is an executive in residence for HealPros, a HEDIS Stars gap closure company in Atlanta, GA, is the executive chairman for Pictor Labs, a digital pathology staining company in Los Angeles, CA, and a strategic advisor for Avanos, a publicly traded medical device company in Atlanta, GA.
Prior to this work, he served as the founding managing director for the American Cancer Society’s BrightEdge Fund, where he built the back office, hired the initial team, led the first five investments, and realized an early exit in Castle Biosciences. Before BrightEdge, he was a partner at Harbert Growth Partners in Birmingham, AL. He led investments in WellCentive, IngagePatient, Caresync and Shipt. He also served as the board observer for nContact, MaxCyte, OpenQ and WiserTogether.
Bob also served as the senior vice president/ general manager of the Pharmaceutical Services Division at US Oncology, a privately held, vertically integrated cancer care provider network with cancer clinics in more than 440 sites of service and a physician network consisting of over 1200 medical oncologists and radiation oncologists that was acquired by McKesson. Prior to US Oncology,he was a senior executive at CardinalHealth where he served as vice president/ general manager of New Ventures. Prior to Cardinal he was the founder and CEO of Surgical Innovations & Services, Inc.(SIS). Under his leadership, SIS became a leader in the emerging outsource management sector, with over 300 hospitals and surgery centers under contract before being acquired by PhotoMedex. Bob is a graduate of the University of Georgia and holds Bachelor of Scien ce degrees in Political Science and Chemistry and resides in Charleston, SC.
Professor Elkins- Tanton is the Foundation and Regents Professor, School Of Earth and Space Exploration at Arizona State University. She is a Vice President and Regents Professor of the Interplanetary Initiative at ASU and Principal Investigator at the NASA Psyche mission. She was on the Faculty of MIT for four years, teaching undergraduate and graduate courses in planetary geology and spent five years as a researcher at Brown University.
Before that, Lindy spent eight years working in business, with five years spent writing business plans for young high-tech ventures. Professor Elkins-Tanton received her bachelor's and master's degrees from MIT. After woking in business, she returned to MIT for her PhD.
John Friedman is a Senior Advisor to Gore Range Capital and Good Growth Capital, and Managing Partner of Easton Capital. Prior to founding Easton, John was Managing GP of Security Pacific Capital, a $200 million private equity fund associated with Security Pacific Bank. Before he joined SecPac, John was a Managing Director/Partner at Warburg, Pincus, where he spent 9 years. Previously, John practiced law at Sullivan and Cromwell.
John has invested in over 100 transactions, with 5 generating returns over 100x. John currently serves on the boards of Trellis Bioscience, Sequella, AOA, and Sensoriant. John has been heavily involved with the New York medical science community for years. He served as Chairman of the Columbia University Medical Center’s Health Sciences Advisory Council and Co-Chairman of the President’s Council at the Cold Spring Harbor Laboratory.
John holds a BA in History from Yale, where he graduated magna cum laude. John also holds a JD degree from Yale.
Krisztina, better known as “Z”, is an investor and advisor for several organizations. She was the Founding Executive Director at the Deshpande Center at MIT and the Founding Director of the Steven Institute for Innovation and the Provost for Innovation at USC. Additionally, she is a Founder of MAKE IT IN LA, an initiative by Los Angeles’ former mayor and was a Council Chair for the World Economic Forum in Davos. Z has served on the Steering Committee for the US National Advisory Council for Innovation and Entrepreneurship, National Academy of Engineering.
She was the Creator, Curator & Host for the first ever TEDx conference. She is an entrepreneur having co-founded Stylus Innovation Inc., which was acquired by Artisoft. Z has mentored over 100 startups in her various roles at MIT, USC, in LA and nationwide. Z earned her MS and BS in Mechanical Engineering from MIT.
Founder and Managing Partner of the Katama Group, consulting for international strategy Leader in VCs and startups for many years, including positions such as Global Managing Director of SOSV Accelerator and SVP of Techstars Former Director of Emerging Business, Facebook
Served in multiple firms in International Business Development, and notably served in the US Department of Commerce as Senior Director, Export Promotion and Trade Policy, for the International Trade Administration JD from Harvard Law, a MIA of International Affairs from Columbia University and his AB from Harvard College
Executive Director, MIT Center for Collective Intelligence and Senior Director, MIT Horizon Lead organizer of The Engine, a new MIT initiative created to advance innovation Former President, MIT Technology Review, and President, MIT Enterprise Forum
Konduros, a licensed attorney since 1990, founded SK Strategies in 2004 – a SC-based consulting firm that specializes in economic development, strategic planning, championing major corporate initiatives, public-private partnerships, integrated marketing & business development strategies, innovation, and vision-mission-brand development – and has guided and supported major institutional and private sector clients over the past two decades ranging from Clemson University to Greenville Health System. He has a demonstrated track record and specialization in industries ranging from advanced manufacturing to healthcare and life sciences. He has also spearheaded major economic development initiatives in multiple corporate roles since 1989, when he joined the SC Department of Commerce after graduating from law school. He is a graduate of Clemson University (1985 magna cum laude, Rhodes Scholar finalist), the University of South Carolina School of Law (1989), and the University of Oklahoma Economic Development Institute (1993). Additionally, Konduros obtained his real estate license in 2012. Highlighted defining career leadership positions include Konduros being tapped at age 30 to lead North American operations for Germany-based automotive supplier Alfmeier Corporation (1990-1994) while also serving as Co-Chair of the BMW Supplier Council, founding President/CEO of Upstate SC Alliance (regional economic development organization 2000-2004), Clemson ICAR’s Economic Development & Marketing Consultant/Senior Development Counsel and ITOR’s Business Development Director (Institute for Translational Oncology Research) as President of SK Strategies (2005-2014 time frame).
During that same period of his career, Konduros also served in voluntary leadership roles as Board Chairman for the Greenville Chamber of Commerce (2011), the Greenville Chamber Foundation (2012), and the Cancer Society of Greenville (2013) along with being a director on multiple boards and councils. Following an 11-year affiliation with Greenville Health System (now Prisma Health), most recently as Executive Director of the Greenville Health Research Development Corporation which championed innovation and industry partnership strategies for one of the largest healthcare providers in the Southeast US, Konduros served as President/CEO of SCBIO (South Carolina Biotechnology Industry Organization) from 2017 to 2021. In that transformational leadership role he focused on scaling-up and leading the innovative statewide economic development and trade organization to its next level of development – fueled by its mission to build, advance, innovate, and grow the life sciences industry and ecosystem in South Carolina and the Southeast US Region, working closely with strategic partners from industry, academia, and the public/private sector - including complementary local, regional, state, and national economic development agencies and industry/trade associations such as the SC Department of Commerce, SC Chamber of Commerce, BIO, PhRMA, AdvaMed, SEMDA and SEBIO among others. Under Konduros’ leadership, SCBIO more than tripled revenue within 3 years and became a formally recognized economic development force in South Carolina and beyond, culminating with the Governor formally proclaiming SCBIO Life Sciences Week during Konduros’ final month in his CEO role (which was quickly followed by organizational achievement of unprecedented legislative funding). SCBIO’s core mission areas included spearheading high-impact initiatives in economic development, advocacy, integrated marketing, innovation/R&D, convening stakeholders (including hosting the state’s largest life sciences conference annually with record breaking attendance for consecutive years), capital attraction and ultimately helping to improve the delivery of healthcare. Konduros was also recruited to serve as President/CEO of KOR Medical in 2021 and on the Vikor Scientific Board of Directors. As CEO, he led efforts to rapidly and strategically build and develop the innovative personalized medicine-focused clinical cannabis life sciences company, and ensure a successful launch of its initial national product portfolio within 7 months, as the newest division of Vikor. Konduros currently serves on the South Carolina Chamber of Commerce Board & Executive Committee as well as South State Bank’s Greenville Advisory Board and the Palmetto Conservation Foundation Board. He has recently served on the Southeast US Life Sciences Association Board, the Carolinas Healthcare Innovation & Technology Association Advisory Council, SC Research Authority Biotech Innovation Advisory Council. Konduros received the Order of the Palmetto from SC Governor Henry McMaster in 2017 (SC’s highest civilian honor), was named to Greenville’s 50 Most Influential People Hall of Fame in 2019, the Chairman’s Award for the Greater Greenville Chamber of Commerce (2008 & 2010), was formally designated as a Knowledge Economist by the South Carolina Research Authority (2007), and was named a South Carolina Ambassador for Economic Development by Governor Jim Hodges (2001). In addition to his current leadership roles, Konduros has also served on the South Carolina Independent Colleges & Universities Board of Directors, Clemson University’s College of Business & Behavioral Science Advisory Board, as Vice Chair for the Board of the American Red Cross Upstate SC Chapter, and as Chair of the Upstate SC Air Service Partnership Committee on behalf of GSP International Airport – charged with helping to successfully recruit Southwest Airlines to Greenville-Spartanburg which propelled unprecedented growth of that world-class facility.
Tanya has over 25+ years of international financial services experience including 12+ years dedicated to M&A as an investment banker and 13+ years dedicated as a venture investor. In 2012, Tanya followed her passion for technology and early stage start-ups and began her VC journey in NYC by co-founding her first Venture fund, CapA, which invested in 18 companies and a top performer globally in fund performance. Moving to Stockholm, Sweden in 2013, CapA invested not only in the US, but also the Nordics.
Tanya joined Finnish based Butterfly Ventures as a partner in 2016 to raise Butterfly Ventures Fund III and expand the fund’s geography to Sweden, Norway, Denmark, and Iceland. Tanya is currently serving as a Board Observer and Board Member for several Butterfly portfolio companies such as TVM Sweden AB and Intelecy AS. She also serves on the Advisory Committee for the European Commission’s (European Investment Bank) €10 Billion EIC Fund investing into Deep Tech. Tanya holds a Bachelor's Degree in Mathematics and Marketing and received a tennis scholarship from Georgia State University.
Physician for Sports Medicine and Concussions
Team Physician for multiple US National Teams and Pro Sports Teams (Washington Nationals, MLB; DC United, MLS, US Canoe/ Kayak, US DragonBoat, Special Olympics)
Researcher at NIH/NCI 10-time World champion paddler
US Olympic Rowing team double scull, 1996
VP of Strategy at Intuitive Surgical (da Vinci Robots) Singularity University Faculty
Former Assistant Professor, Stanford, Department of Surgery MD, Stanford; MS, BS, MIT
Director of MIT’s Technology Licensing Office for 25 years - Retired Former President and awardee of the Bayh-Dole Award of the Association of Technology Managers
Currently consultant in licensing and technology management for biotechnology companies; SAB member of several biotech companies; board member of Celdara MBA (Sloan Fellow at MIT), B.S.. & MS Chemical Engineering.
Special Advisor to the President for Corporate Relations at the Medical University of South Carolina (MUSC)
Former Board member, COO, President and Head of R&D, Forest Laboratories
Former President and CEO of Celsion Corporation
Co-founder of the Technology Accelerator Company, TAC Development LLC
Advisor Former Sr VP Clinical Research and Development at Sandoz Pharmaceutical Corporation
Former Corporate VP-Clinical Development and Medical Affairs at The Upjohn Company BSChE, Tufts, MS, Rutgers,
PhD Biomedical Engineering and MD, Case Western Reserve
Serial Entrepreneur Director of Product at Tempus, Precision Medicine via AI
VP of Product at Zest Health Northwestern U, MS Comp & Info Systems U of Michigan, BA
CTO & Founder Ember
CEO & Founder BlueDot /weMonitor Founder of Wireless Industrial Network Alliance & Cool Energy World
IoT Consultant
Board Member ViE Tech MIT PhD Media Lab
Founder and Director MIT Alumni Angels (Boston Healthcare & West Coast )
President & CEO, Savran Technologies Serial Entrepreneur
President and CEO of: Cerno Fluidics, Sonogenix, Bioabsorbable Therapeutics (acq by Multi- Cell Corporation), SMART Therapeutics (acq by Boston Scientific)
VP of Target Therapeutics (acq by Boston Scientific)
MBA, MIT; BA Harvard
Managing Partner at Moss Valley Capital, LLC, a private investment fund. Previously, Partner at Applied Invention, LLC, a multi-disciplinary innovation company that designs and builds technology solutions in partnership with leading corporations as well as incubates companies. Founding board member of Apeiron Labs, Inc., a company dedicated to transforming our understanding of the state of our oceans; previously served on the boards of directors and as an advisor to several private companies.
Co-author of “Effective vs Nominal Valuations in Venture Capital Investing” in the NYU Journal of Law and Business and “Understanding Anti-Dilution Provisions in Convertible Securities” in the Fordham Law Review. JD, New York University School of Law; MALD, Fletcher School of Law & Diplomacy; BA, University of Rochester
Dave has more than 30 years of experience leading technology change at large, multinational companies including AstraZeneca, GE, Honeywell and Flextronics. Most recently, Dave was VP of Software Engineering at Apple Computer where his team was responsible for building, deploying, and running digital solutions across the $365B revenue company.
Dave has a degree in Computer Science from Clemson and an MBA from the University of Virginia Darden School of Business.
Over 30 years building companies and high performance teams Principal – Momenta Consulting CEO, Intac International. Private equity-backed, sold in 2017 CEO and co-founder of PlumRiver Technology (now PlumRiver software) Principal, Bell Tower Partners
Professor of Medicine & Oncology; Johns Hopkins University School of Medicine: Clinical Chief, Division of Pulmonary and Critical Care; Director, Interventional Pulmonology; Director, Interventional Pulmonary Outcomes Group Johns Hopkins, MBA; Harvard, PB; Emory, DO, UNE, BA
Andy started his career at Connecticut Spring & Stamping (CSS) as VP of Operations. He then instigated an HBS study of the perennial success of the Toyota Production System (TPS). The study culminated in groundbreaking reports introducing and detailing the DNA of TPS, leading to a reimagining of many of the production and operations classes taught at HBS. The published materials garnered so much interest from the business community, Andy chose to establish YOMO Consulting, the core principles which are the consolidated key learnings of Toyota’s success.
For over 20 years, YOMO’s mission was to help companies improve their businesses through implementation of TPS. In 2015, Andy created a curriculum for the Stanford Graduate School of Business and served as professor of “The Cultural Imperative,” a course that shows students how to design company cultures with happier, more gratified, and more productive employees. Andy invests, consults, and advises companies that are up to the twin challenge of improving both themselves and the planet. Andy graduated with an MBA from Harvard Business School and earned his Bachelor’s degree from Dartmouth College.
MIT Senior Lecturer in Entrepreneurship Created the Innovation Teams program at MIT’s Deshpande Center Faculty in Innovation, Olin College, Berklee College of Music and Jack Welsh Management Institute
Founder: Rethink Robotics, Egenera, Geer Zolot, Spectra Communications Mentor to TechStars, The Deshpande Foundation, The Levin Institute of New York City, Mass.
ChallengehackNY, and FIRST Robotics MS in Management of Technology, MIT; BS Computer Science, Syracuse University